Immix Biopharma Inc. (IMMX) at a glance

Immix Biopharma Inc. (IMMX) is a small-cap Healthcare company. It trades at $13.91, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Momentum (80/100) and its weakest is Income (40/100).

Price
$13.91
Market cap
$601.6M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.94 to $15.10
Vestovix Score53/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
80

Other Healthcare stocks

See all